Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Kan

Neurological Surgery Galveston, TX Medical Doctor

NPI 1215124805 CMS profile 54522

301 University Blvd, Galveston, TX 77555

Open in the dashboard

General payments

$276,428

276 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,493,547 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Peter Kan of Galveston, TX is reported in the CMS Open Payments database as having received $276,428 across 276 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,493,547 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $88,071 64
2024 General $31,203 42
2023 General $49,408 40
2022 General $29,824 35
2021 General $22,905 40
2020 General $14,120 22
2019 General $40,895 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Kan
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Peter Kan were reported at $88,071. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Peter Kan Neurological Surgery median Middle half National median
2019 $40,895 $582 $138–$3,006 $163
2020 $14,120 $294 $76–$2,174 $114
2021 $22,905 $387 $105–$2,432 $132
2022 $29,824 $542 $139–$2,989 $149
2023 $49,408 $534 $145–$2,697 $160
2024 $31,203 $574 $155–$3,046 $164
2025 $88,071 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $209,845 203 payments
  2. MicroVention, Inc. $26,315 20 payments
  3. Medical Device Business Services, Inc. $25,013 10 payments
  4. Imperative Care, INc $6,234 19 payments
  5. Penumbra, Inc. $4,187 3 payments
  6. Siemens Medical Solutions USA, Inc. $2,896 2 payments
  7. Corindus Inc. $393 2 payments
  8. Medtronic, Inc. $284 2 payments
  9. Balt USA, LLC $271 3 payments
  10. Silk Road Medical, Inc. $260 2 payments
  11. Other $729 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $186,975 51 payments
  2. Travel and Lodging $54,752 104 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,350 11 payments
  4. Food and Beverage $10,101 109 payments
  5. Honoraria $250 1 payment
Products named General payments · program years 2019–2025
  1. SURPASS EVOLVE $101,606 87 payments
  2. PULSERIDER $25,129 13 payments
  3. TRUFILL $23,963 9 payments
  4. NEUROFORM ATLAS $23,384 5 payments
  5. WEB $19,383 10 payments
  6. SALVATION $18,448 10 payments
  7. AXS CATALYST 7 $10,863 5 payments
  8. LUXOR $10,797 9 payments
  9. INVISION $10,405 2 payments
  10. SYNCHRO SELECT $10,405 2 payments
  11. Other $67,431 114 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$53,312

Medicare's payments for the services billed

Medicare patients

81

Average age 72

Services billed

301

60 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 41%
Diabetes 31%
Chronic kidney disease 26%
COPD 26%
Depression 26%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

276 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record